50 likes | 170 Views
Neuropathic pain results from damage or dysfunction of the peripheral and central nervous system (CNS). Pain can develop after injury to any level of the nervous system. Some of the major syndromes include postherpetic neuralgia, painful traumatic mononeuropathy, root avulsions, painful polyneuropathy, central pain syndromes, postsurgical pain syndromes, and complex regional pain syndrome.
E N D
NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020 PersistenceMarketResearch NeuropathicPainMarket:GlobalIndustry AnalysisandForecast2014-2020 1 PersistenceMarketResearch
NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020 PersistenceMarketResearchReleasedNewMarketReporton“NeuropathicPainMarket: GlobalIndustryAnalysisandForecast2014-2020”. Neuropathicpainresultsfromdamageordysfunctionoftheperipheralandcentralnervoussystem(CNS). Paincandevelopafterinjurytoanylevelofthenervoussystem.Someofthemajorsyndromesinclude postherpeticneuralgia,painfultraumaticmononeuropathy,rootavulsions,painfulpolyneuropathy,central painsyndromes,postsurgicalpainsyndromes,andcomplexregionalpainsyndrome.Mostcommonly prescribedmedicationsforneuropathicpainincludeantidepressants(alsoknownastricyclic antidepressants),anticonvulsants(alsocalledneurolepticmedications),andanesthetics.Major antidepressantsincludeNortriptilineandAmitriptyline.Carbamazepine,ValproicAcid,Felbamate, Clonazepam,andPhenytoinarethemostcommonlyusedanticonvulsantsforthetreatmentof neuropathicdisorders.MajoranestheticsusedtoreduceneuropathicpainareTocainideorMexiletineand Idocaine.Antidepressantsandanticonvulsantsarethefirstlineoftreatmentforneuropathicpain.The combinationofthesetwomedicationsisthoughttobeparticularlyeffectiveinthetreatmentofneuropathic pain. BuyFullReport:http://www.persistencemarketresearch.com/market-research/neuropathic-pain- market.asp Theglobalneuropathicpainmarketiscategorizedbasedonvariousformsofneuropathicpainandtheir therapeutics.Basedontypes,thereportcoverspostherpeticneuralgia,painfuldiabeticneuropathy,and trigeminalneuralgia.Thedrugsegmentisfurthersub-segmentedintoantidepressants,cannabinoids, dietarysupplements,neuromodulators,anticonvulsantstopicaltreatments,N-methyl-D-aspartate(NMDA) antagonism,opioids,andtopicalagents. Intermsofgeography,NorthAmericadominatestheglobalneuropathicpainmarket.Thisisdueto increasedawarenessaboutneuropathicpaindisordersandtechnologicaladvancementsindiagnostic proceduresintheregion.TheU.S.representsthelargestmarketforneuropathicpaininNorthAmerica, followedbyCanada.InEurope,Germany,France,theU.K.,Italy,andSpainaccountforamajorshareof theneuropathicpainmarket.ThemarketinAsiaisexpectedtoexpandatasignificantrateoverthenext fiveyears.Thisisduetovariouscompaniessettingupmanufacturingfacilitiesintheregion.Moreover, increasingawarenessaboutneuropathicpaindisordersandriseingeriatricpopulationarealsodriving thegrowthofthemarketintheregion.India,ChinaandJapanareexpectedtobethefastestgrowing neuropathicpainmarketsinAsia. 2 PersistenceMarketResearch
NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020 Inrecenttimes,increaseddemandfordiagnosticandtherapeuticproductstomanageneuropathicpain disordersisthekeydriveroftheglobalneuropathicpainmarket.IncreasedinvestmentsinR&Dinthe pharmaceuticalsectorandintroductionofinnovativedrugshavealsofueledthegrowthofthismarket. Ongoingdevelopmentofdrugswithpropertiessuchasimprovedsafetyandhighpatientcomplianceare alsosupportingthegrowthofthepainmarket.Therapies,suchasbiologicaltherapyandphysiotherapy haveimmensepotentialtospurthegrowthofthismarket. However,stringentregulationsbyvariousgovernmentshamperthegrowthoftheglobalneuropathicpain market.Moreover,thepatentexpiryofsomeblockbusterdrugs(drugsthathaveanannualsaleofUSD 1.0millionandabove)andriskofcomplicationsandside-effectsassociatedwithantidepressantsand anticonvulsantshavehinderedthegrowthofthemarket.Increasingmergersandacquisitionsofdrug manufacturingcompaniesandrapidproductlaunchesaresomeofthemajortrendsintheglobal neuropathicpainmarket. ThemajorcompaniesoperatinginthismarketareConvergencePharmaceuticals,DaiichiSankyo Company,Limited,JanssenPharmaceuticals,Inc.,EndoPharmaceuticalsInc.,GrünenthalGmbH, AmgenInc.,BaxterHealthcareCorporation,BiogenIdec,Inc.,Bristol-MyersSquibb,EliLillyand Company,GEHealthcare,GlaxoSmithKlineplc,PfizerInc.,SanofiS.A.,andTevaPharmaceutical IndustriesLtd. RequestFullTOC:http://www.persistencemarketresearch.com/toc/4149 Keypointscoveredinthereport:- 1. Reportsegmentsthemarketonthebasisoftypes,application,products,technology,etc (asapplicable) Thereportcoversgeographicsegmentation NorthAmerica Europe Asia RoW Thereportprovidesthemarketsizeandforecastforthedifferentsegmentsand geographiesfortheperiodof2010to2020 Thereportprovidescompanyprofilesofsomeoftheleadingcompaniesoperatinginthemarket Thereportalsoprovidesportersfiveforcesanalysisofthemarket. 2. 3. 4. 5. 3 PersistenceMarketResearch
NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020 Browsethefull“AllUpcomingPersistenceMarket's”reportat http://www.persistencemarketresearch.com/forthcoming-reports.asp AboutUs: PersistenceMarketResearchisaglobalmarketresearchfirmspecializing-syndicated research,customresearch,andconsultingservices AtPersistenceMarketResearch(PMR),weareinthebusinessofacceleratingyourbusiness. Asafull-servicemarketresearchfirm,westandcommittedtobringingmoreaccuracyandspeedtoyourbusinessdecisions.Fromready-to-purchasemarketresearchreportstocustomizedglobalresearchsolutions,ourengagementmodelsarehighlyflexiblewithoutcompromisingonourdeep-seatedresearchvalues.Brieflystated,ourmissionistogiveyouaccesstoforecastsandtrendsanalysesthatputyouonthepathtoprofitability. PMR’sServicesGoBeyondGleaningData: MostenterprisesbelievethatITanddatabasesareenoughtomakeanaccuratedecision.Whilewedonotdisputethat,considerthis:Howlongdoesittaketomakeanaccurateandstrategicmillion-dollardecision?Westrivetodeliverbothevenwithdemandingdeadlines. FacilitatingRapidandInformedBusinessDecisions PMRwasfoundedwithonegoalinmind:toofferenterprisesatangiblebusinessadvantagebycarefullybalancingtraditionalandmodern-dayresearchmethodologies. ContactUs: AddieThomes 305Broadway, 7thFloor, NewYorkCity,NY10007,UnitedStates. Phone:+1-646-568-7751 USA/CanadaTollFreeNumber. 1-800-961-0353 E-mail:Sales@persistencemarketresearch.com Web:http://www.persistencemarketresearch.com/ 4 PersistenceMarketResearch
NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020NeuropathicPainMarket:GlobalIndustryAnalysisandForecast2014-2020 5 PersistenceMarketResearch